The total return over the past 12 months is +174.40% vs. +16.94% for the S&P 500. So far it's up +162.15% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +174.40% | (4.10%) | (27.63%) | N/A | N/A | N/A |
| Total Return CAGR | +174.40% | (4.10%) | (27.63%) | N/A | N/A | N/A |
| Revenue CAGR | (3.28%) | (27.32%) | (17.68%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Maravai LifeSciences Holdings, Inc. (MRVI)
| Year | Start price | End price | MRVI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.25 | $8.52 | +162.15% | +14.51% | +147.64% |
| 2025 | $5.45 | $3.25 | (40.37%) | +17.72% | (58.09%) |
| 2024 | $6.55 | $5.45 | (16.79%) | +24.89% | (41.68%) |
| 2023 | $14.31 | $6.55 | (54.23%) | +26.19% | (80.42%) |
| 2022 | $41.90 | $14.31 | (65.85%) | (18.17%) | (47.68%) |
| 2021 | $28.05 | $41.90 | +49.38% | +28.74% | +20.64% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
